DAVITA BASIC TRAINING FINAL EXPECTED QUESTIONS
WITH VERIFIED ANSWERS
Question 1.
why do we document in the medical record?
ANSWER
proof of care
data continuity
permanent legal record
communication
Question 2.
In KT/V what is T?
ANSWER
time
Question 3.
explain the difference between AKI and CRF
ANSWER
AKI is a sudden loss of function with restoring function still possible
CRF is not reversible
Question 4.
6 occurrences when to chart
ANSWER
1. baseline assessment change
2. change in condition
3. procedure or treatment
4.medication and response
5.patient teaching
6. care plan review and interventions
1/8
, Question 5.
3 thing not to include in an AOR
ANSWER
i. Opinion
ii. Speculation
iii. Vendetta
Question 6.
observations during
treatment are to be charted
ANSWER
as they occur
Question 7.
lab draw mistakes that would falsely decrease Kt/V
ANSWER
Diluting pre BUN sample
waiting longer than 15 seconds
Question 8.
times to chart
ANSWER
pre, intra, and post dialysis
Question 9.
pretreatment safety checks
ANSWER
to be done before initiation of treatment
2/8
WITH VERIFIED ANSWERS
Question 1.
why do we document in the medical record?
ANSWER
proof of care
data continuity
permanent legal record
communication
Question 2.
In KT/V what is T?
ANSWER
time
Question 3.
explain the difference between AKI and CRF
ANSWER
AKI is a sudden loss of function with restoring function still possible
CRF is not reversible
Question 4.
6 occurrences when to chart
ANSWER
1. baseline assessment change
2. change in condition
3. procedure or treatment
4.medication and response
5.patient teaching
6. care plan review and interventions
1/8
, Question 5.
3 thing not to include in an AOR
ANSWER
i. Opinion
ii. Speculation
iii. Vendetta
Question 6.
observations during
treatment are to be charted
ANSWER
as they occur
Question 7.
lab draw mistakes that would falsely decrease Kt/V
ANSWER
Diluting pre BUN sample
waiting longer than 15 seconds
Question 8.
times to chart
ANSWER
pre, intra, and post dialysis
Question 9.
pretreatment safety checks
ANSWER
to be done before initiation of treatment
2/8
